Updated September 2026
Short answer: 630 and 660 nm are visible red wavelengths, while 810, 830 and 850 nm are near-infrared (NIR) and not visible to the eye. Red and NIR differ in how they interact with tissue, but wavelength alone does not determine whether a session works. The output at your actual distance, exposure time, treatment area and the outcome you care about matter too. Research has not established a universal winner among these five numbers (Zein et al., review of PBM parameters).
Key takeaways
- Visible red wavelengths are often discussed for more superficial targets; NIR is often selected when deeper tissue exposure is a consideration. This is an optical distinction, not proof of a specific clinical result (Zein et al.).
- 660 nm versus 850 nm is chiefly a comparison of visible red and NIR. Neither number is automatically “stronger.”
- More wavelengths on a label do not establish better outcomes. Look for stated output, measurement distance, coverage and usable instructions.
- A wavelength chart cannot replace dose. Start with our dosage and frequency guide before copying anyone else's session time.
What does a wavelength number mean?
A nanometer (nm) is a unit of wavelength. A red LED specified at 660 nm emits light in the visible red portion of the spectrum; an 850-nm LED emits NIR light that is largely invisible. The visible glow of a combination panel does not reveal how much NIR is reaching your skin. To compare devices, you need their actual wavelength specification and irradiance measured at a stated distance (Zein et al.; study of home-use LED device output).
These numbers describe nominal LED peaks, not a promise that every photon comes from exactly one wavelength. More importantly, a study involving one light source, skin site and dose does not validate every device with the same nominal wavelength.
How do the five common wavelengths compare?
| Wavelength | Light category | Useful way to think about it | Evidence caution |
|---|---|---|---|
| 630 nm | Visible red | One of several red wavelengths used in skin-focused PBM research | Do not infer that 630 nm alone treats a skin condition or outperforms 660 nm |
| 660 nm | Visible red | A common red-panel wavelength and a practical starting point for comparing red versus NIR | No basis for calling it universally “the best” wavelength |
| 810 nm | Near-infrared | Used in a variety of PBM experiments; often discussed for deeper-tissue exposure | A result from a contact laser cannot be copied directly to a standing LED panel |
| 830 nm | Near-infrared | Another studied NIR wavelength; often found in multi-wavelength devices | Different studies use different doses, devices and outcomes |
| 850 nm | Near-infrared | A common NIR LED-panel wavelength | Deeper optical reach alone does not prove improved recovery or joint outcomes |
This table is an orientation aid, not a condition-to-wavelength prescription. A review of photobiomodulation parameters generally distinguishes red light around 600–700 nm from longer NIR wavelengths used when deeper exposure is sought, while emphasizing variation by tissue and study design (Zein et al.). For a broader comparison that also separates infrared heat from PBM, see red versus infrared versus near-infrared.
Does near-infrared always penetrate deeper?
NIR generally has a different absorption-and-scattering profile from visible red, which is why it is frequently considered for targets below the most superficial skin layers. But “penetrates deeper” should not become an unqualified number of centimeters or a promise to reach a particular joint. Skin pigmentation, blood, body site, beam geometry and the amount of light reaching the surface affect what arrives farther down. The published review describes broad wavelength tendencies, not a universal depth for a consumer panel (Zein et al.).
Surface dose and absorbed tissue dose are not interchangeable. If a panel delivers 73 mW/cm² to the surface at six inches, the arithmetic for five minutes is 73 × 300 ÷ 1,000 = 21.9 J/cm² at the surface. That example uses the specified HG300 figure at six inches; it is not a measurement inside muscle, a target dose, or an estimate for a different distance. For the full explanation of irradiance and its limitations, see our dosage guide and panel-distance guide.
660 nm versus 850 nm: which should you choose?
Think of 660 nm as a visible red option and 850 nm as a NIR option, not two competing scores. If you are comparing a skin-focused device with a larger panel, consider the area you need to illuminate and whether the device offers clear directions for your intended use. A panel offering both gives you a way to select or combine modes when its controls allow that, but a combined-mode panel is not automatically clinically superior to a well-specified single-mode device (Zein et al.).
Avoid claims that 660 nm “makes collagen” and 850 nm “repairs joints” as if those outcomes follow from wavelength alone. Mechanistic and preclinical observations are not the same as proof of a meaningful outcome for a particular consumer device.
Are 810, 830 and 850 nm interchangeable?
They are all NIR, but they are not literally the same wavelength. Their appearance on a product label tells you little about the treatment actually delivered unless you also know output, distance, exposure, coverage and the underlying evidence. Research protocols involving 810 or 830 nm sometimes use contact lasers or localized applicators, which differ materially from a non-contact full-body LED array (review of human muscle-tissue studies). A claim that adding 810 and 830 nm to an 850-nm panel is “proven better” would require a suitable head-to-head clinical comparison, not merely a longer specification list.
How should you use this information when buying a panel?
- Choose the format and coverage first. A face mask, small panel and larger panel serve different practical setups. See our mask-versus-panel guide.
- Check the stated wavelengths and controls. Can you select red, NIR or both? Are the wavelengths listed for the specific model you are buying?
- Check irradiance at your use distance. A close-range measurement is not the output at every distance; even home-use LED devices can vary in measured output and dose consistency (home-use device study).
- Follow the model's own instructions. Do not copy a laser trial's schedule or a different panel's minute count.
- Compare products transparently. Hooga sells these devices, so our HG, PRO and ULTRA comparison reflects a manufacturer's perspective. You can also browse the red-light panel collection for current specifications.
Frequently asked questions
Can you see 850-nm light?
The NIR emission itself is not visible the way 660-nm red light is. A device may still appear bright because of its red LEDs or a faint glow from components; neither visual cue measures NIR irradiance.
Is a four-wavelength panel necessarily better than a two-wavelength panel?
No head-to-head outcome follows from wavelength count alone. Compare output at the intended distance, coverage, controls, instructions and your actual use case.
Is 660 nm or 850 nm better for skin?
Visible red light such as 660 nm is frequently discussed for more superficial exposure, while 850 nm is NIR. Neither wavelength alone establishes a better skin outcome across devices and protocols; compare the evidence for the specific goal and follow the device instructions (Zein et al.). This guide covers the comparison on the existing URL rather than creating a competing page.
References and editorial disclosure
- Zein R, Selting W, Hamblin MR. Review of light parameters and photobiomodulation efficacy. Journal of Biomedical Optics. 2018.
- Ferraresi C et al. Photobiomodulation in human muscle tissue. Review of sports and muscle studies. 2016.
- Photobiomodulation LED Devices for Home Use. 2025. Cited for measurement variability, not for any Hooga-specific result.
Written by: Hooga Editorial Team. Hooga has designed and sold photobiomodulation devices since 2019. This educational guide draws on published research, device specifications and practical product experience; it is not independent third-party buying advice or medical guidance. Last updated: September 2026.